Metabolic modeling-based drug repurposing in Glioblastoma

Claudio Tomi-Andrino, Alina Pandele, Klaus Winzer, John King, Ruman Rahman, Dong-Hyun Kim

Open source

DOI
10.1038/s41598-022-14721-w
Published
2022-07-01
Container
Scientific Reports
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-022-14721-w,
  title = {Metabolic modeling-based drug repurposing in Glioblastoma},
  author = {Claudio Tomi-Andrino and Alina Pandele and Klaus Winzer and John King and Ruman Rahman and Dong-Hyun Kim},
  year = {2022},
  journal = {Scientific Reports},
  doi = {10.1038/s41598-022-14721-w},
  url = {https://doi.org/10.1038/s41598-022-14721-w}
}

RIS

TY  - JOUR
TI  - Metabolic modeling-based drug repurposing in Glioblastoma
AU  - Claudio Tomi-Andrino
AU  - Alina Pandele
AU  - Klaus Winzer
AU  - John King
AU  - Ruman Rahman
AU  - Dong-Hyun Kim
PY  - 2022
JO  - Scientific Reports
DO  - 10.1038/s41598-022-14721-w
UR  - https://doi.org/10.1038/s41598-022-14721-w
ER  - 

APA

Tomi-Andrino, C., Pandele, A., Winzer, K., King, J., Rahman, R., & Kim, D. (2022). Metabolic modeling-based drug repurposing in Glioblastoma. Scientific Reports. https://doi.org/10.1038/s41598-022-14721-w

Source records